Rgs14 is a protein that acts as a regulator of G-protein signaling pathways by accelerating the GTPase activity of G-protein alpha subunits and thereby converting them to their inactive GDP-bound form. The impact of Rgs14 expression on inflammatory bowel disease was investigated in a mouse model.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Chronic and hard-to-heal wounds
Benefit from the advantages of outpatient negative pressure wound therapy
- COPD
Even a single moderate exacerbation can be a predictor of mortality
- HER2+ metastatic breast cancer
New therapeutic standards with SHR-A 1811
- Angina tonsillaris: clinical management
Conservative therapy or surgery?
- Dermocosmetic for mild to moderate acne
Effects of an anti-pimple cream: randomized split-face study
- Neuro-ophthalmology
Visual Snow Syndrome: From the mysterious disorder to effective treatment options
- Platelet and leukocyte abnormalities
Clonal or reactive causes?
- Gonarthrosis and coxarthrosis: update on conservative treatment